Patent · US Active

Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

US8580293B2 · kind B2 · utility

3Cited by

45References

21Claims

0Family size

Assignee

TEVA WOMEN'S HEALTH, INC. · US

Inventors

Salah U. Ahmed · New City, US
Jiaxiang Tsao · Nanuet, US
Anu Mahashabde · Kendall Park, US
Diane D. Harrison · Villanova, US

Key dates

Filing date	Feb 3, 2009
Grant date	Nov 12, 2013
Priority date	—
Expiry date	Jan 21, 2030

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB29L2031/753
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.